A Study of Teriparatide in Japanese Osteoporosis Patients
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to assess the effects on serum calcium when teriparatide is used
with active vitamin D in osteoporosis patients.
This study consists of a Screening Period, a 14-day Lead-in Period, a 28-day Treatment
Period, and a 7-day Follow-up Period. Patients will take vitamin D and calcium
supplementation from the Lead-in Period throughout the study. During the Treatment Period,
daily administration of teriparatide will be added.